Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of LNP1955 in moderate to severe rheumatoid arthritis
2016-001532-35Phase 2Completed
- Sponsor
- Lupin Limited
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing LNP1955 dose-ranging with Placebo (2 arms). Primary endpoint: ACR20 response at Week 12. Started Jun 2016; status: completed.
02
Drugs
LNP1955
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2016-001532-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001532-35.